Mira Pharmaceuticals appoints Matthew Pratt Whalen to board, replacing Michael Jerman

MIRA PHARMACEUTICALS, INC.

Michael Jerman resigned as director and Audit Committee Chair effective Nov 18, 2024, not due to any disagreement.
Matthew Pratt Whalen appointed as director and Audit Committee Chair effective same day.
Whalen is a CPA with over 20 years experience, currently CFO of Power Digital Marketing since May 2021.
Whalen also serves as director on the board of Telmoir Pharmaceuticals (NASDAQ: TELO) since August 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.